The emerging role of electronic medical records in pharmacogenomics.
Health-care information technology and genotyping technology are both advancing rapidly, creating new opportunities for medical and scientific discovery. The convergence of these two technologies is now facilitating genetic association studies of unprecedented size within the context of routine clinical care. As a result, the medical community will soon be presented with a number of novel opportunities to bring functional genomics to the bedside in the area of pharmacotherapy. By linking biological material to comprehensive medical records, large multi-institutional biobanks are now poised to advance the field of pharmacogenomics through three distinct mechanisms: (i) retrospective assessment of previously known findings in a clinical practice-based setting, (ii) discovery of new associations in huge observational cohorts, and (iii) prospective application in a setting capable of providing real-time decision support. This review explores each of these translational mechanisms within a historical framework.
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. russell.a.wilke@vanderbilt.edu
R A
RA
Wilke
H
H
Xu
J C
JC
Denny
D M
DM
Roden
R M
RM
Krauss
C A
CA
McCarty
R L
RL
Davis
T
T
Skaar
J
J
Lamba
G
G
Savova
D003661:Decision Support Techniques; D057286:Electronic Health Records / Q000639:trends*; D056726:Genetic Association Studies / Q000379:methods; D023281:Genomics; D005838:Genotype; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010597:Pharmacogenetics / Q000639:trends*; D012107:Research Design
D004364:Pharmaceutical Preparations
PLoS One. 2007 Sep 05;2(9):e840
17786211
Acta Oncol. 2010 Apr;49(3):305-12
20156115
Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7
20235204
J Biomed Inform. 2004 Jun;37(3):139-46
15196479
Pharmacogenomics. 2007 Nov;8(11):1511-9
18034616
N Engl J Med. 1998 Feb 19;338(8):499-505
9468466
Proc AMIA Symp. 2000;:270-4
11079887
Pharmacogenet Genomics. 2005 Jun;15(6):415-21
15900215
Am J Med Genet A. 2009 Feb;149A(2):188-98
19161150
Per Med. 2005 Mar;2(1):49-79
29793241
N Engl J Med. 2008 Jul 3;359(1):50-60
18565855
Nat Rev Drug Discov. 2007 Nov;6(11):904-16
17971785
Drug Metab Dispos. 2002 Nov;30(11):1280-7
12386136
Pharmacogenomics. 2010 May;11(5):637-41
20415552
Clin Pharmacol Ther. 2010 Jan;87(1):65-73
19794410
N Engl J Med. 1976 Dec 9;295(24):1351-5
988482
N Engl J Med. 2008 Aug 21;359(8):789-99
18650507
Am J Public Health. 1977 Mar;67(3):240-5
842761
Yearb Med Inform. 2008;:128-44
18660887
Med Decis Making. 2008 Jul-Aug;28(4):462-70
18480037
JAMA. 2008 Nov 26;300(20):2417-9
19033592
Basic Clin Pharmacol Toxicol. 2008 Oct;103(4):354-9
18834356
N Engl J Med. 2010 Jan 21;362(3):192-5
20089969
Mayo Clin Proc. 2007 Sep;82(9):1065-8
17803873
J Clin Oncol. 2010 May 10;28(14):2423-9
20385997
N Engl J Med. 2009 Feb 19;360(8):753-64
19228618
AMIA Annu Symp Proc. 2007 Oct 11;:908
18694008
Pharmacogenetics. 2004 Aug;14(8):523-5
15284534
Clin Pharmacol Ther. 2008 Sep;84(3):362-9
18500243
Science. 1999 Oct 15;286(5439):487-91
10521338
Int J Med Inform. 2009 Apr;78(4):284-91
18838293
Nat Rev Drug Discov. 2005 Nov;4(11):911-8
16264434
Lancet. 2010 May 1;375(9725):1525-35
20435227
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7898-903
20385806
Ann Pharmacother. 2010 May;44(5):885-97
20371752
BMJ. 2010 Feb 08;340:c693
20142325
J Clin Epidemiol. 2007 Aug;60(8):812-8
17606177
N Engl J Med. 2010 Apr 1;362(13):1235-6
20220178
Int J Med Inform. 2009 Apr;78 Suppl 1:S34-42
18938105
PLoS One. 2010 Mar 22;5(3):e9763
20339536
Circulation. 2008 Mar 25;117(12):1537-44
18332269
Clin Pharmacol Ther. 2009 Aug;86(2):197-203
19474787
Am J Hum Genet. 2010 Apr 9;86(4):560-72
20362271
N Engl J Med. 2009 Apr 16;360(16):1628-38
19321858
J Biomed Inform. 2007 Feb;40(1):47-54
16617035
Prev Cardiol. 2009 Spring;12(2):88-94
19476582
J Am Med Inform Assoc. 2010 Jan-Feb;17(1):19-24
20064797
Breast Cancer Res Treat. 2009 Jun;115(3):643-50
19082882